...
首页> 外文期刊>International journal of infectious diseases : >Nocardia spp infections among hematological patients: results of a retrospective multicenter study
【24h】

Nocardia spp infections among hematological patients: results of a retrospective multicenter study

机译:血液病患者的诺卡氏菌感染:一项回顾性多中心研究的结果

获取原文

摘要

Objectives: To describe the clinical characteristics and prognostic factors of hematological patients affected by Nocardia spp infections. Methods: We retrospectively evaluated all the cases diagnosed in four Italian institutions. Results: Between 2002 and 2012, 10 cases of nocardiosis were recorded. The median age of the patients was 66 years (range 24-85 years). The underlying hematological disease was a lymphoproliferative disorder in all but two patients. Eight patients (80%) showed active underlying hematological disease, relapsed or refractory in five (50%); one patient had a history of previous allogeneic bone marrow transplantation. Eight patients (80%) were on steroid therapy; lymphopenia was present in 8/10 (80%) patients. All patients showed lung involvement. Six patients were affected by disseminated nocardiosis. Three patients (30%) were nocardemic and three (30%) showed central nervous system involvement. Skin, lymph nodes, and bone were involved in one patient each. The median overall survival was 65 days. Older age, a longer period between hematological diagnosis and Nocardia spp infection, and relapsed/refractory hematological disease were associated with a worse prognosis. Conclusions: Although rare, nocardiosis should be considered in the differential diagnosis of pulmonary and central nervous system lesions among hematological patients. Lymphoproliferative disorders, prolonged steroid treatment, lymphopenia, and active hematological disease are the conditions that are worth considering as predisposing factors for the development of this disease.
机译:目的:描述受诺卡氏菌感染的血液病患者的临床特点和预后因素。方法:我们回顾性评估了在四个意大利机构中诊断出的所有病例。结果:2002年至2012年间,记录了10例心肌病。患者的中位年龄为66岁(范围24-85岁)。潜在的血液系统疾病是除两名患者以外的所有患者的淋巴增生性疾病。八名患者(80%)表现出活跃的潜在血液病,其中五名患者(50%)复发或难治。一名患者曾有异基因骨髓移植史。八名患者(80%)接受类固醇治疗; 8/10(80%)患者存在淋巴细胞减少。所有患者均显示有肺受累。六例患者发生了弥漫性心肌病。 3例(30%)为无心肌病,三例(30%)表现为中枢神经系统受累。皮肤,淋巴结和骨骼分别涉及一名患者。中位总生存期为65天。年龄较大,血液学诊断和诺卡氏菌感染之间的间隔时间较长以及复发/难治性血液病与预后较差有关。结论:尽管不常见,但在血液学患者中肺部和中枢神经系统病变的鉴别诊断中应考虑使用诺卡替尼。淋巴增生性疾病,长时间的类固醇治疗,淋巴细胞减少症和活动性血液病是值得考虑作为该病发展的诱发因素的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号